BHST BIOHARVEST SCIENCES INC. NASDAQ · United States

BIOHARVEST SCIENCES INC. (BHST) news

BIOHARVEST SCIENCES INC. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker BHST, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest BIOHARVEST SCIENCES INC. news

We have not published a story on BIOHARVEST SCIENCES INC. yet. When there is news, it will appear here.

BIOHARVEST SCIENCES INC. annual financials

Line	FY2025	FY2024
Revenue	$34.5 million	$25.2 million
Net income (loss)	-$11.1 million	-$12.9 million
Cash from operations	-$7.2 million	-$6.7 million
Cash and equivalents	$23.0 million	$2.4 million

Latest balance sheet, Dec 31, 2025 (40-F): cash and equivalents $23.0 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about BIOHARVEST SCIENCES INC.

What is the ticker symbol of BIOHARVEST SCIENCES INC.?

BIOHARVEST SCIENCES INC. trades under the ticker BHST on NASDAQ.

Where is BIOHARVEST SCIENCES INC. listed?

BIOHARVEST SCIENCES INC. is listed on NASDAQ.

Which country or territory is BIOHARVEST SCIENCES INC. listed under?

Our directory records BIOHARVEST SCIENCES INC. under United States.

Does aibio.space cover BIOHARVEST SCIENCES INC.?

aibio.space lists BIOHARVEST SCIENCES INC. among 2,820 public biotech companies and publishes its news here as stories appear.

What was BIOHARVEST SCIENCES INC.'s revenue last year?

$34.5 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is BIOHARVEST SCIENCES INC. profitable?

BIOHARVEST SCIENCES INC. reported a net loss of $11.1 million for the fiscal year ended Dec 31, 2025, and used $7.2 million of cash in operations, per its annual report to the SEC.

How much cash does BIOHARVEST SCIENCES INC. have?

$23.0 million in cash at Dec 31, 2025, per its 40-F.

Investor discussion: BIOHARVEST SCIENCES INC.

Members talk about BIOHARVEST SCIENCES INC. (BHST). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at BIOHARVEST SCIENCES INC., newest first. Each line links the filing it comes from.

Oct 2, 2026Financings
Reported a financing. SEC Form 6-K. Source
Aug 11, 2026Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. Source
May 14, 2026Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:BHST on TradingView.

Listing details

Company: BIOHARVEST SCIENCES INC.
Ticker: BHST
Listing: NASDAQ
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction